MiRXES is a Singaporean biotech company that’s listed on the Hong Kong stock exchange. Today Elaine Boey will be sitting down with co-founder and CEO, Dr. Zhou Lihan to talk about the technology that the company employs, challenges as Southeast Asia’s biotech unicorn, when it might turn profitable, and whether you should be a shareholder.

Image Credit: Shutterstock.com

Produced by: Deena Khadeja

Presented by: Elaine Boey

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  wellness,  managing disease,  medical advances

Tags:  Southeast Asia’s biotech unicorn,  MiRXES,  singaporean company,  biotechnology,  hong kong stock exchange,